Q32 Bio Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $53.7 | $0.0 | $1.2 | $3.2 | $34.0 |
| Operating income | $16.9 | -$66.1 | -$48.3 | -$133.3 | -$95.9 |
| Net income | $29.8 | -$47.7 | -$53.7 | -$5.0 | -$95.8 |
| Cash Flow Statement | |||||
| Free cash flow | -$33.5 | -$67.8 | -$18.7 | -$114.9 | -$112.1 |
Shares outstanding 29.8M · Free float 60.5%
Annual filing data through FY ended December 31, 2025; float as of September 12, 2026.